Search fresh public links, source activity, and ready-to-use post angles for Insulin.
Fresh curated links around Insulin are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
A new oral insulin embedded in sugar-free chocolate uses nano-carriers to target the liver, cutting hypoglycemia risk. The post Could a Piece of Chocolate Replace Your Daily Insuli...
In a groundbreaking advancement poised to deepen our understanding of diabetes and pancreatic function, a team of researchers has unveiled pivotal insights into the molecular regul...
The product will be imported from Denmark and is priced at ₹2611 for a 1 ml pen (700 insulin units)
A trial led by University of Pittsburgh researchers and published today in The Lancet Diabetes & Endocrinology adds nuance to the question of whether older human insulins are a...
Topical Insulin Accelerates Wound Healing in Diabetes by Enhancing the AKT and ERK Pathways: A Double-Blind Placebo-Controlled Clinical Trial Maria H. M. Lima, et al PLoS ONE 7(5...
Novo Nordisk has launched Awiqli (insulin icodec), the world’s first once-weekly basal insulin, in India. The company says the therapy could reduce the injection burden from 365 to...
The U.S. Food and Drug Administration has approved Afrezza (insulin human) Inhalation Powder for use in children and adolescents aged 6 years and older who are living with type 1 o...
A large international study found that an experimental oral diabetes medication produced significant improvements in both glucose control and weight loss. For millions of people wi...
The immunotherpay can give children and adults three extra years before they need to use insulin.
Retatrutide is designed to control appetite and blood sugar but also increase body’s energy expenditure, unlike other drugsA new triple-action weekly jab for type 2 diabetes could...
Around six million people in the UK are thought to be living with type 2 diabetes, which occurs when the body does not produce enough insulin or cannot use it properly.
"The first drug that can delay the onset of type 1 diabetes is being made available on the NHS in England and Wales.Teplizumab is a form of immunotherapy that can give people thre...
This brings real hope.ScienceAlert stories are written, fact-checked, and edited by humans, never generated by AI. Don't miss a story, subscribe here.
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.